Sharemaestro Newsreel

5 Insightful Analyst Questions From STAAR Surgical’s Q2 Earnings Call

STAAR Surgical's Q2 results exceeded analyst expectations for revenue and adjusted earnings, driven by increased adoption of EVO Plus in China and market share gains. Despite the positive financial performance, the market reacted negatively, raising questions about growth sustainability. The article highlights key analyst …

Summit Creek Advisors LLC Acquires Shares of 85,118 Addus HomeCare Corporation $ADUS

Summit Creek Advisors LLC has acquired 85,118 shares of Addus HomeCare Corporation (ADUS), valued at approximately $8.55 million, making it their fifth-largest holding. Institutional investors own 95.35% of Addus HomeCare, with other major holders including BlackRock and Vanguard. The company recently reported strong quarterly …

Tenon Medical, Inc. SEC Filing (Aug 19, 2026)

This article reports on a Tenon Medical, Inc. SEC Filing, specifically an EFFECT filing for a Shelf Registration Statement (Form S-3) that became effective on August 18, 2026, at 5:00 P.M. The filing indicates a neutral impact and sentiment. The article also provides recent …

Immuron (IMRN) lifts FY26 sales as it shifts to partner-funded drug development

Immuron Ltd (IMRN) reported a 6% increase in global sales revenue to A$7.7 million for FY2026, driven by strong performance in Australia and the U.S. The company is strategically repositioning itself as a commercially focused biopharmaceutical business, relying on over-the-counter products like Travelan and …

BMO initiates Prime Medicine stock with outperform rating

BMO Capital has initiated coverage on Prime Medicine (NASDAQ:PRME) with an outperform rating and a $9.00 price target, representing a nearly 3x upside. The firm highlighted Prime Editing as a differentiated gene-editing platform and noted that Prime Medicine's lead programs, PM577 and PM647, are …

REG - AstraZeneca PLC - Director/PDMR Shareholding

AstraZeneca PLC announced that its Chief Financial Officer, Dr. Aradhana Sarin, had 11,133 ordinary shares vest on August 17, 2026, under the AstraZeneca Performance Share Plan (AZPSP). This award, granted on August 13, 2021, and subject to performance and a two-year holding period, is …

Rice Hall James & Associates LLC Purchases New Position in U.S. Physical Therapy, Inc. $USPH

Rice Hall James & Associates LLC has acquired a new position in U.S. Physical Therapy, Inc. (NYSE:USPH), purchasing 18,628 shares valued at approximately $1.28 million. This comes as U.S. Physical Therapy reported an 8.5% year-over-year increase in quarterly revenue to $214.1 million, despite missing …

Here's Why We're Watching Pliant Therapeutics' (NASDAQ:PLRX) Cash Burn Situation

Pliant Therapeutics (NASDAQ:PLRX), an unprofitable biopharmaceutical company, has a cash runway of about 2.2 years based on its current cash burn rate of US$71 million annually and US$158 million in cash reserves as of June 2026. While the company's cash burn decreased by 59% …

UnitedHealth Group Incorporated $UNH Shares Bought by Kelleher Financial Advisors

Kelleher Financial Advisors significantly increased its stake in UnitedHealth Group (UNH) by 135.9% in the second quarter, now holding 5,495 shares valued at $2.28 million. Institutional investors and hedge funds collectively own 87.86% of UNH. Despite positive analyst ratings and strong quarterly earnings, the …

Private Advisory Group LLC Decreases Position in UnitedHealth Group Incorporated $UNH

Private Advisory Group LLC reduced its stake in UnitedHealth Group Incorporated by 7.9% in the second quarter, selling 3,461 shares and holding 40,598 shares valued at $16.9 million. UnitedHealth reported strong quarterly EPS of $6.38, exceeding estimates, with revenue of $112.03 billion, and reaffirmed …

Meeder Advisory Services Inc. Invests $4.42 Million in Gilead Sciences, Inc. $GILD

Meeder Advisory Services Inc. has invested $4.42 million in Gilead Sciences, Inc. by acquiring 34,965 shares during the second quarter, making it one of several institutional investors increasing their stake in the biopharmaceutical company. Gilead Sciences reported strong quarterly revenue of $7.8 billion, exceeding …

190,044 Shares in CVS Health Corporation $CVS Bought by Wealthfront Advisers LLC

Wealthfront Advisers LLC has acquired a new position in CVS Health Corporation, purchasing 190,044 shares valued at approximately $19.66 million during the second quarter. This move comes as CVS reported strong Q2 results, exceeding analyst expectations with EPS of $2.58 and revenue of $106.1 …

What's Going On With Becton Dickinson Stock Wednesday?

Becton, Dickinson and Company (NYSE: BDX) saw its stock rise about 3% on Wednesday after the FDA announced the company issued a correction for specific convenience kits containing recalled sodium chloride ampules from Huons Co., Ltd. Patients could be exposed to endotoxins or other …

Trust Co. of Vermont Purchases New Position in Amgen Inc. $AMGN

Trust Co. of Vermont recently acquired a new stake in Amgen Inc., purchasing 22,744 shares valued at approximately $8.24 million during the second quarter. This move comes as other institutional investors have also adjusted their positions in the medical research company. Amgen has reported …

Amgen Inc. $AMGN Shares Purchased by Simplicity Wealth LLC

Simplicity Wealth LLC significantly increased its stake in Amgen Inc. (NASDAQ:AMGN) during the second quarter, more than doubling its position to 10,539 shares valued at $3.8 million. This comes as Amgen reported strong quarterly results with revenue up 9.5% and EPS exceeding analyst estimates, …

HCA Healthcare stock trades above $410 as recent earnings and institutional demand shape outlook

Hikari Power Ltd Sells 22,090 Shares of Amgen Inc. $AMGN

Hikari Power Ltd has significantly reduced its stake in Amgen Inc. by selling 22,090 shares, decreasing its holdings by 71.3% during the second quarter. Following this transaction, the firm now owns 8,900 shares of Amgen, valued at $3.22 million. Other institutional investors have also …

290,935 Shares in Humana Inc. $HUM Acquired by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. has acquired a new stake of 290,935 shares in Humana Inc. (NYSE:HUM), valued at approximately $115.56 million. Other large institutional investors have also adjusted their holdings in Humana. The stock currently holds a "Hold" consensus rating from analysts …

Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in DexCom, Inc. $DXCM

Mitsubishi UFJ Asset Management Co. Ltd. has acquired a new position in DexCom, Inc. (NASDAQ:DXCM) during the second quarter, purchasing over 1.3 million shares valued at approximately $89.94 million. This makes Mitsubishi UFJ Asset Management Co. Ltd. a significant institutional holder, owning about 0.35% …

Plato Investment Management Ltd Buys Shares of 11,681 DexCom, Inc. $DXCM

Plato Investment Management Ltd recently acquired 11,681 shares of DexCom, Inc. (NASDAQ:DXCM), valued at approximately $782,000, as disclosed in their latest SEC filing. This acquisition is part of a trend where institutional investors hold a significant portion of DexCom's stock. The article also details …

IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer

IDEAYA entered into a clinical collaboration to evaluate IDE892, IDEAYA's potential best-in-class Phase 1 MTA-cooperative PRMT5 inhibitor, in combination with RG6620, Genentech's Phase 1 KRAS G12D inhibitor, in MTAP-deleted, KRAS G12D-mutant pancreatic ductal adenocarcinoma Genentech will sponsor the clinical trial, and there will be …

2,901 Shares in Thermo Fisher Scientific Inc. $TMO Bought by MidFirst Bank

MidFirst Bank acquired 2,901 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) during the second quarter, valuing the new stake at approximately $1.45 million. This purchase is part of broader institutional investment, with various hedge funds also adjusting their positions in TMO, while company insiders …

Pallas Capital Advisors LLC Takes $920,000 Position in Becton, Dickinson and Company $BDX

Pallas Capital Advisors LLC has acquired a new position of 6,076 shares, valued at approximately $920,000, in Becton, Dickinson and Company (BDX). This comes as institutional investors collectively own 86.97% of BDX. The company recently reported strong quarterly earnings, beating analyst estimates, and announced …

33,810 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by UNIVEST FINANCIAL Corp

Pallas Capital Advisors LLC Takes $1.13 Million Position in Align Technology, Inc. $ALGN

Pallas Capital Advisors LLC has acquired a new position in Align Technology, Inc. (NASDAQ:ALGN) by purchasing 6,689 shares valued at approximately $1.13 million during the second quarter. This move comes as institutional investors collectively own 88.43% of the company, and analysts maintain a "Moderate …

Inspire Medical Systems (INSP) Q2 2026 Earnings Call Transcript

Biogen stock hits 52-week high at 219.94 USD

Biogen (BIIB) stock has reached a new 52-week high of $219.94, driven by positive market sentiment, product pipeline developments, and strategic business decisions. The company reported strong Q2 results, exceeding analyst expectations, and raised its full-year 2026 revenue outlook. Analysts have responded by increasing …

BTIG Adjusts Price Target on Henry Schein to $110 From $100, Maintains Buy Rating

BTIG has increased its price target for Henry Schein (HSIC) to $110 from $100, while reiterating a Buy rating on the stock. This adjustment reflects an updated outlook from the analyst firm for the dental and medical product distributor. Henry Schein specializes in the …

Mitsubishi UFJ Asset Management Co. Ltd. Invests $147.94 Million in HCA Healthcare, Inc. $HCA

Mitsubishi UFJ Asset Management Co. Ltd. recently acquired a new stake in HCA Healthcare, purchasing 379,450 shares valued at approximately $147.94 million in the second quarter, representing 0.18% of the company's stock. Other institutional investors have also adjusted their holdings in HCA Healthcare, which …

2,710 Shares in HCA Healthcare, Inc. $HCA Acquired by Perigon Wealth Management LLC

Perigon Wealth Management LLC acquired 2,710 shares of HCA Healthcare, Inc. (NYSE:HCA) valued at approximately $1.06 million during the second quarter. The article details other institutional investments, analyst ratings, and the company's financial performance, including exceeding quarterly expectations and declaring a $0.78 per share …

R.H. Investment Group LLC Buys New Shares in Thermo Fisher Scientific Inc. $TMO

R.H. Investment Group LLC has acquired a new stake of 9,168 shares in Thermo Fisher Scientific Inc. (NYSE:TMO) during the second quarter, valued at approximately $4.596 million, making it their 16th largest holding. Other institutional investors also modified their holdings in TMO, while company …

5,081 Shares in Danaher Corporation $DHR Bought by Perigon Wealth Management LLC

Perigon Wealth Management LLC recently acquired 5,081 shares of Danaher Corporation (NYSE:DHR) valued at approximately $968,000 during the second quarter. Danaher reported strong quarterly results, with revenue of $6.26 billion and adjusted earnings of $1.94 per share, surpassing analyst estimates. The company maintains a …

26,698 Shares in Thermo Fisher Scientific Inc. $TMO Purchased by Perigon Wealth Management LLC

Perigon Wealth Management LLC has acquired 26,698 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) valued at approximately $13.4 million during the second quarter. This move is part of broader institutional investment, with other firms also adjusting their positions in the medical research company. Despite …

Legend Biotech (LEGN) Turns Profitable In Q2, Is The Stock Cheap?

Bionano (BNGO) Q2 2026 Results: EPS Exceeds Its Estimate at the Close; Latest Reaction: Shares Fall 0.84% in Latest Trading - Long-Term Guidance

Haleon offers to buy back $1.34B of 3.375% senior notes due 2027, settlement expected Aug 21.

Haleon plc announced a tender offer to repurchase up to $1.34 billion of its 3.375% Fixed Rate Senior Notes due March 2027. The offer, which expired on August 18, 2026, is contingent on the successful issuance of new USD-denominated senior notes expected by August …